Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway

Resistance to first-line chemotherapy drugs has become an obstacle to improving the clinical prognosis of patients with small cell lung cancer (SCLC). Exosomal microRNAs have been shown to play pro- and anti-chemoresistant roles in various cancers, but their role in SCLC chemoresistance has never be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Shan, Wulin, Hua, Yan, Chao, Fengmei, Cui, Yayun, Lv, Lei, Dou, Xiaoyan, Bian, Xing, Zou, Jinglu, Li, Hong, Lin, Wenchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201786/
https://www.ncbi.nlm.nih.gov/pubmed/34136482
http://dx.doi.org/10.3389/fcell.2021.661602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201786/
https://www.ncbi.nlm.nih.gov/pubmed/34136482
http://dx.doi.org/10.3389/fcell.2021.661602

Ejemplares similares